Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Metabotropic glutamate (mGlu) receptors provide a mechanism by which the function of NMDA glutamate receptors can be modulated. As NMDA receptor hypofunction is implicated in the etiology of psychiatric disorders, including schizophrenia, the pharmacological regulation of mGlu receptor activity represents a promising therapeutic approach. We examined the effects of the positive allosteric mGlu5 receptor modulator 3- cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB), alone and in combination with the NMDA receptor antagonist MK-801, on a task measuring cognitive set-shifting ability. This task measures NMDA receptor-dependent cognitive abilities analogous to those impaired in schizophrenia. Systemic administration of CDPPB (10 & 30 mg/kg i.p) blocked MK-801 (0.1 mg/kg, i.p.)-induced impairments in set-shifting ability. The effect on learning was dose-dependent, with the 30 mg/kg dose having a greater effect than the 10 mg/kg dose across all trials. This ameliorative effect of CDPPB reflected a reduction in MK-801-induced perseverative responding. These results add to the evidence that mGlu5 receptors interact functionally with NMDA receptors to regulate behavior, and suggest that positive modulators of mGlu5 receptors may have therapeutic potential in the treatment of disorders, like schizophrenia, characterized by impairments in cognitive flexibility and memory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Effects of Different Brain Lesions on Card Sorting: The Role of the Frontal Lobes
MILNER, B. (1963) · Archives of Neurology · doi:10.1001/archneur.1963.00460070100010 · Cited by 2,217 · cited 1×
“Our task is analogous to the Wisconsin Card Sort Task used to assess cognitive flexibility in humans (Haut et al., 1996; Milner, 1963).”
MethodMedial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat
Birrell, J. M., & Brown, V. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04320.2000 · Cited by 1,421 · cited 2×
“Cognitive set-shifting refers the ability to switch between rules in response to environmental feedback (Birrell and Brown, 2000; Ragozzino et al., 1999; Shepp and Eimas, 1964).”
BackgroundBaude, A., Nusser, Z., Roberts, J. D. B., Mulvihill, E., Jeffrey Mcllhinney, R. A., & Somogyi, P. (1993) · Neuron · doi:10.1016/0896-6273(93)90086-7 · Cited by 927 · cited 1×
“…the mGlu1 and mGlu5 subtypes, are localized largely at the periphery of the post-synaptic active zone, where they regulate ionotropic receptor activity and intracellular processes via G protein-linked second messenger pathways (Baude et al., 1993; Hassel and Dingledine, 2006; Luján et al., 1997).”
BackgroundMultiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting
Floresco, S. B., Magyar, O., Ghods-Sharifi, S., Vexelman, C., & Tse, M. T. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300825 · Cited by 395 · cited 2×
“…shifting ability depends on glutamatergic and dopaminergic neurotransmission within the medial prefrontal cortex (Egerton et al., 2005; Floresco et al., 2005; Ragozzino et al., 2002; Stefani and Moghaddam, 2005; Stefani and Moghaddam, 2006) and is sensitive to manipulations which…”
BackgroundGlutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability
Stefani, M. R., Groth, K., & Moghaddam, B. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.4.728 · Cited by 164 · cited 7×
“…arms were defined as the two start arms from which responding, during set 2, according to the set 1 discrimination rule would result in a (spuriously) correct, rewarded response (see Stefani et al., 2003; Stefani and Moghaddam, 2005, for illustrations and discussion of start arm classes).”
BackgroundSelf-citationManahan-Vaughan, D., & Braunewell, K.-H. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhi047 · Cited by 138 · cited 3×
“Selective mGlu5 receptor antagonists typically impair cognition and enhance deficits caused by NMDA antagonists (Homayoun et al., 2004; Manahan-Vaughn and Braunewell, 2005).”
BackgroundMelendez, R. I., Lee Gregory, M., Bardo, M. T., & Kalivas, P. W. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300507 · Cited by 104 · cited 2×
“(Lecourtier et al., 2007; Melendez et al., 2004; Packard et al., 2001; Page et al., 2005; Romano et al., 1995).”
Background
Cited by
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Impact of anxiety on prefrontal cortex encoding of cognitive flexibility
Park, J., & Moghaddam, B. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.013 · Cited by 218
“pharmacological manipulations of the rat medial PFC (mPFC) result in markedly impaired performance in these and other set-shifting tasks that assess behavioral flexibility (Birrell and Brown, 2000; Ragozzino et al., 2003; Stefani et al., 2003; Bissonette et al., 2008; Darrah et al., 2008; Floresco et al., 2008; Stefan…”
InfluentialSelf-citationGass, J. T., Glen, W. B., McGonigal, J. T., Trantham-Davidson, H., Lopez, M. F., Randall, P. K., Yaxley, R., Floresco, S. B., & Chandler, L. J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.109 · Cited by 197
“This compound, 3-cyano-N-(1,3diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB), is a positive allosteric modulator of the type 5 metabotropic glutamate receptor (mGluR5) and has been shown to have procognitive effects in other behavioral tasks (Ayala et al, 2009; Horio et al, 2013; Stefani and Moghaddam, 2010; Uslaner et al,…”
Drug targets for cognitive enhancement in neuropsychiatric disorders.
Wallace, T. L., Ballard, T. M., Pouzet, B., Riedel, W. J., & Wettstein, J. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.022 · Cited by 127
Metadata
- Authors
- Stefani, M. R., & Moghaddam, B.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 639
- Issue
- 1-3
- Pages
- 26-32
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2004785265
- Cited by
- 100
- References
- 8
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.